Linde to discuss capabilities to improve quality and safety of biotech and pharma operations at NC Bioscience conference

Oct 14, 2013, 08:32 ET from Linde North America

MURRAY HILL, N.J. and NEW PROVIDENCE, N.J., Oct. 14, 2013 /PRNewswire/ -- Biotech and pharmaceutical firms looking for ways to improve the quality and safety of their operations are invited to meet with cryogenic gases experts from Linde Gas North America LLC., at the North Carolina Bioscience conference to be held at the North Carolina Biotechnology Center in Research Triangle Park. Linde representatives will be available during the networking dinner on October 17, as well at the annual conference on October 18.

(Logo: )

Peter Stuber, program manager-Chemistry for Linde Gas North America LLC, said, "The Bioscience conference gives Linde an opportunity to outline its capabilities for biotechnology and pharmaceutical industry processes. As a preferred BIO Business Solutions Partner with the Biotechnology Industry Organization (BIO), Linde offers member companies technical know-how, special pricing and rebates on gases such as oxygen, nitrogen, carbon dioxide, and specialty gas mixtures. With more than 50 production facilities and 220 active distributor locations throughout the U.S., Linde offers exceptional service and cost-saving benefits to members companies."

Linde will also highlight the advantages of two of its cryogenic systems:

  • Linde Cryoservices™ which is specially designed to serve all the requirements of biotech organizations that need to cryogenically store irreplaceable specimens, such as cord blood, bone marrow, cell lines, blood and organs for transfusion and transplantation.
  • VERISEQ® Nucleation, a proprietary technology for nucleation control during lyophilization (freeze drying) of pharmaceuticals and biologics.

Linde Gas North America LLC. is a member of the Linde Group, a world-leading gases and engineering company with around 62,000 employees in more than 100 countries worldwide. In the 2012 financial year, Linde generated revenue of EUR 15.280 bn (USD 19.9 bn). The strategy of the Group is geared towards long-term profitable growth and focuses on the expansion of its international business with forward-looking products and services. Linde acts responsibly towards its shareholders, business partners, employees, society and the environment – in every one of its business areas, regions and locations across the globe. The company is committed to technologies and products that unite the goals of customer value and sustainable development.

For more information, see The Linde Group online at

SOURCE Linde North America